Bausch & Lomb Corp
BLCO: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$21.00 | Zfcjdr | Ygbvqxjg |
Bausch & Lomb: Interested Buyers Prepare Bids as Potential Sale Work Underway
The Financial Times reported on Sept. 18 that a number of private equity firms, including Blackstone, Advent International, and TPG, are considering offers for Bausch & Lomb. While there is no guarantee that the firm will be sold off, this increasingly looks to be a more likely option than a spinoff, given that Bausch Health—Bausch & Lomb’s parent company, which owns about 88% of its subsidiary—could use the proceeds to pay down its USD 21.2 billion in long-term debt.